Porsolt & Metris Sign a Co-Marketing Agreement
News Nov 26, 2009
Porsolt and Partners Pharmacology (Porsolt) and Metris have announced that they have entered into a global co-marketing agreement to promote preclinical screening services using Laboras , a non-invasive technology for automatic and comprehensive in vivo behavioral characterization of drug candidates.
Under this alliance, Porsolt will offer CRO services utilizing the in vivo screening platform to its clients. The Laboras system enables the measurement of multiple behavioral pharmacodynamic endpoints in a single experiment utilizing a high throughput non-invasive system.
Dr. Martine Lemaire, Senior Director - Commercial & Business Development of Porsolt said, “We are thrilled by the synergy between Porsolt’s long-established and recognized expertise in behavioral pharmacology and the high-quality, proven utility of the Laboras innovative technology system.
This partnership has formed in response to the needs expressed by Porsolt’s clients for increased information on drug-like molecules earlier in the drug discovery process. It fits obviously with our strategy to constantly deliver superior quality scientific solutions tailored to our customer’s need.”
Worms Exhibit Fear and Respond to Anti-anxiety MedsNews
A team of investigators has uncovered new clues about the mechanisms of fear and anxiety through an unlikely creature: the tiny nematode worm.READ MORE
New Studies Demonstrate Risk Reduction Potential of Heat-Not-Burn Tobacco Products and e-CigarettesNews
Data presented at the Society of Toxicology Annual Meeting (SOT) have demonstrated the potential of two different heat-not-burn tobacco products and e-cigarettes to reduce the risk of smoking-related diseases, in comparison to continued use of conventional cigarettes.READ MORE
Exposure to Low Levels of BPA during Pregnancy Can Lead to Altered Brain DevelopmentNews
New research in mice provides an explanation for how exposure to the widely used chemical bisphenol A (BPA) during pregnancy, even at levels lower than the regulated “safe” human exposure level, can lead to altered brain development and behavior later in life.READ MORE